Association between obesity and probability of each component in MDA
| Univariable model | Multivariable model * | |||
| OR (95% CI) | P | OR (95% CI) | P | |
| Tender joint count≤1 | 0.62 (0.41, 0.93) | 0.021 | 0.71 (0.45, 1.13) | 0.152 |
| Swollen joint count≤1 | 0.73 (0.47, 1.13) | 0.154 | 0.78 (0.48, 1.28) | 0.328 |
| PASI≤1 or BSA≤3% | 0.68 (0.34, 1.35) | 0.274 | 0.55 (0.25, 1.18) | 0.123 |
| HAQ≤0.5 | 0.39 (0.26, 0.60) | <0.001 | 0.52 (0.32, 0.83) | 0.007 |
| Pain≤1 | 0.40 (0.23, 0.69) | 0.001 | 0.50 (0.27, 0.91) | 0.023 |
| PGA≤2 | 0.63 (0.42, 0.95) | 0.027 | 0.81 (0.51, 1.28) | 0.369 |
| Tender entheseal site≤1 | 0.54 (0.31, 0.94) | 0.030 | 0.64 (0.33, 1.23) | 0.635 |
Bold: statistically significant.
*Regression model adjusted with age and sex.
bDMARDs, biological disease modifying anti-rheumatic drugs; BSA, body surface area; csDMARDs, conventional synthetic disease modifying antirheumatic drugs; DAPSA, Disease Activity in PSoriatic Arthritis; FCI, Functional comorbidity index; HAQ, Health Assessment Questionnaire; LDA, low disease activity status; PASI, Psoriasis Area and Severity Index; PGA, patient global assessment.